Concepedia

Natalya I. Vasilevich

NI

Statistics

Publications

8

Citations

314

H-Index

8

Active since

2003

Affiliations

Tulane University(Current)

Ligand Pharmaceuticals (United States)

Io Therapeutics (United States)

Carolina Veterinary Specialists

Natalya I. Vasilevich is an author at Tulane University specializing in drug discovery, medicinal chemistry, and pharmacology.

ORCID

Publications per year

2003–2012

8

Publications

8

Examination of the 1,4-disubstituted azetidinone ring system as a template for combretastatin A-4 conformationally restricted analogue design

Lichun Sun, Natalya I. Vasilevich, Joseph A. Fuselier et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 74 citations

, , +13

Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitors

Dmitry O. Koltun, Eric Q. Parkhill, Natalya I. Vasilevich et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 59 citations · Full text

, , +10

Lessons from Natural Products Chemistry Can Offer Novel Approaches for Synthetic Chemistry in Drug Discovery

Natalya I. Vasilevich, Roman Kombarov, Dmitry V. Genis et al. · Journal of Medicinal Chemistry · 2012 · 46 citations

, , +8

Orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors

Dmitry O. Koltun, Natalya I. Vasilevich, Eric Q. Parkhill et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 45 citations · Full text

, , +10

An adjustable release rate linking strategy for cytotoxin–Peptide conjugates

Joseph A. Fuselier, Lichun Sun, S.Nathaniel Woltering et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 34 citations · Full text

, , +14

1–5 of 8